Long-Term Safety and Efficacy of Elagolix Treatment in Women with Endometriosis-Associated Pain: Primary Results From Two Phase 3 Extension Studies

Study Objective: To evaluate the long-term safety and efficacy of elagolix, an oral, non-peptide gonadotropin-releasing hormone antagonist, for the management endometriosis-associated pain.